{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T14:49:32Z","timestamp":1782226172490,"version":"3.54.5"},"reference-count":37,"publisher":"Galenos Yayinevi","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Turk Gogus Kalp Dama"],"accepted":{"date-parts":[[2024,12,11]]},"published-print":{"date-parts":[[2025,1,1]]},"abstract":"<jats:p>\n                    <jats:bold>\n                      <jats:italic>Background:<\/jats:italic>\n                    <\/jats:bold>\n                    This study aimed to assess the outcomes of valve-in-valve implantation within previously placed bioprosthetic valves.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>\n                      <jats:italic>Methods:<\/jats:italic>\n                    <\/jats:bold>\n                    This single-center retrospective study included patients who underwent percutaneous valve-in-valve procedures between July 2014 and September 2023. These patients had previously received pulmonary bioprosthetic valves via surgical or transcatheter methods.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>\n                      <jats:italic>Results:<\/jats:italic>\n                    <\/jats:bold>\n                    The study included 20 patients (13 males, 7 females; mean age: 20.4\u00b17.1 years; range, 10.8 to 35.8 years). Preprocedural assessment revealed stenotic dysfunction in 12 patients, regurgitant dysfunction in two patients, and a combination of both in six patients. Following implantation, there was a notable improvement in invasive measurements; systolic right ventricular pressure decreased from 64.0\u00b124.5 mmHg to 31.3\u00b16.7 mmHg (p&lt;0.001), right ventricular outflow tract gradient from 44.0\u00b123.2 mmHg to 7.6\u00b15.8 mmHg (p&lt;0.001), and echocardiographic pulmonary regurgitation grade from 2.1\u00b11.2 to 0.2\u00b10.4 (p&lt;0.001). The median time between initial bioprosthetic pulmonary valve placement and valve-in-valve procedure was 8.2 years (IQR, 6.2 to 9.9 years). The median follow-up duration was 24.8 months (IQR, 8.3 to 40.2 months). Only one patient required a repeat PPVI procedure 10 years after the valve-in-valve procedure, while no other patients required reintervention during the follow-up period.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>\n                      <jats:italic>Conclusion:<\/jats:italic>\n                    <\/jats:bold>\n                    Valve-in-valve implantation within previously placed bioprosthetic valves is a feasible and safe approach, offering symptom relief and eliminating the need for further surgical interventions.\n                  <\/jats:p>","DOI":"10.5606\/tgkdc.dergisi.2025.26622","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T01:21:52Z","timestamp":1740360112000},"page":"36-45","source":"Crossref","is-referenced-by-count":0,"title":["Early-term results of percutaneous pulmonary valve implantation (valve-in-valve) in dysfunctional bioprosthetic valves in pulmonary position"],"prefix":"10.4274","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0868-8009","authenticated-orcid":false,"given":"Ensar","family":"Duras","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8485-0376","authenticated-orcid":false,"given":"Erman","family":"\u00c7ilsal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3812-2081","authenticated-orcid":false,"given":"Selman","family":"G\u00f6kalp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7319-4139","authenticated-orcid":false,"given":"Sezen","family":"Ugan Atik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6799-9638","authenticated-orcid":false,"given":"Murat","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1661-7024","authenticated-orcid":false,"given":"Bekir","family":"Y\u00fckc\u00fc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1924-9036","authenticated-orcid":false,"given":"Alper","family":"G\u00fczelta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2811","published-online":{"date-parts":[[2025,1,31]]},"reference":[{"key":"ref-1","doi-asserted-by":"crossref","unstructured":"Therrien J, Marx GR, Gatzoulis MA. Late problems in tetralogy of Fallot--recognition, management, and prevention. Cardiol Clin 2002;20:395-404. doi: 10.1016\/ s0733-8651(02)00010-3.","DOI":"10.1016\/S0733-8651(02)00010-3"},{"key":"ref-2","doi-asserted-by":"crossref","unstructured":"Piazza L, Chessa M, Giamberti A, Bussadori CM, Butera G, Negura DG, et al. Timing of pulmonary valve replacement after tetralogy of Fallot repair. Expert Rev Cardiovasc Ther 2012;10:917-23. doi: 10.1586\/erc.12.67.","DOI":"10.1586\/erc.12.67"},{"key":"ref-3","doi-asserted-by":"crossref","unstructured":"Vricella LA, Kanani M, Cook AC, Cameron DE, Tsang VT. Problems with the right ventricular outflow tract: A review of morphologic features and current therapeutic options. Cardiol Young 2004;14:533-49. doi: 10.1017\/ S1047951104005116.","DOI":"10.1017\/S1047951104005116"},{"key":"ref-4","doi-asserted-by":"crossref","unstructured":"Giugno L, Faccini A, Carminati M. Percutaneous pulmonary valve implantation. Korean Circ J 2020;50:302-16. doi: 10.4070\/kcj.2019.0291.","DOI":"10.4070\/kcj.2019.0291"},{"key":"ref-5","doi-asserted-by":"crossref","unstructured":"Chen PC, Sager MS, Zurakowski D, Pigula FA, Baird CW, Mayer JE Jr, et al. Younger age and valve oversizing are predictors of structural valve deterioration after pulmonary valve replacement in patients with tetralogy of Fallot. J Thorac Cardiovasc Surg 2012;143:352-60. doi: 10.1016\/j.jtcvs.2011.10.079.","DOI":"10.1016\/j.jtcvs.2011.10.079"},{"key":"ref-6","doi-asserted-by":"crossref","unstructured":"Nomoto R, Sleeper LA, Borisuk MJ, Bergerson L, Pigula FA, Emani S, et al. Outcome and performance of bioprosthetic pulmonary valve replacement in patients with congenital heart disease. J Thorac Cardiovasc Surg 2016;152:1333-42. e3. doi: 10.1016\/j.jtcvs.2016.06.064.","DOI":"10.1016\/j.jtcvs.2016.06.064"},{"key":"ref-7","doi-asserted-by":"crossref","unstructured":"Lee C, Park CS, Lee CH, Kwak JG, Kim SJ, Shim WS, et al. Durability of bioprosthetic valves in the pulmonary position: Long-term follow-up of 181 implants in patients with congenital heart disease. J Thorac Cardiovasc Surg 2011;142:351-8. doi: 10.1016\/j.jtcvs.2010.12.020.","DOI":"10.1016\/j.jtcvs.2010.12.020"},{"key":"ref-8","doi-asserted-by":"crossref","unstructured":"Asoh K, Walsh M, Hickey E, Nagiub M, Chaturvedi R, Lee KJ, et al. Percutaneous pulmonary valve implantation within bioprosthetic valves. Eur Heart J 2010;31:1404-9. doi: 10.1093\/eurheartj\/ehq056.","DOI":"10.1093\/eurheartj\/ehq056"},{"key":"ref-9","doi-asserted-by":"crossref","unstructured":"Shahanavaz S, Berger F, Jones TK, Kreutzer J, Vincent JA, Eicken A, et al. Outcomes after transcatheter reintervention for dysfunction of a previously implanted transcatheter pulmonary valve. JACC Cardiovasc Interv 2020;13:1529-40. doi: 10.1016\/j.jcin.2020.03.035.","DOI":"10.1016\/j.jcin.2020.03.035"},{"key":"ref-10","doi-asserted-by":"crossref","unstructured":"Geva T. Repaired tetralogy of Fallot: The roles of cardiovascular magnetic resonance in evaluating pathophysiology and for pulmonary valve replacement decision support. J Cardiovasc Magn Reson 2011;13:9. doi: 10.1186\/1532-429X-13-9.","DOI":"10.1186\/1532-429X-13-9"},{"key":"ref-11","doi-asserted-by":"crossref","unstructured":"Gregg D, Foster E. Pulmonary insufficiency is the nexus of late complications in tetralogy of Fallot. Curr Cardiol Rep 2007;9:315-22. doi: 10.1007\/BF02938380.","DOI":"10.1007\/BF02938380"},{"key":"ref-12","doi-asserted-by":"crossref","unstructured":"O'Byrne ML, Glatz AC, Mercer-Rosa L, Gillespie MJ, Dori Y, Goldmuntz E, et al. Trends in pulmonary valve replacement in children and adults with tetralogy of fallot. Am J Cardiol 2015;115:118-24. doi: 10.1016\/j.amjcard.2014.09.054.","DOI":"10.1016\/j.amjcard.2014.09.054"},{"key":"ref-13","doi-asserted-by":"crossref","unstructured":"Tweddell JS, Pelech AN, Frommelt PC, Mussatto KA, Wyman JD, Fedderly RT, et al. Factors affecting longevity of homograft valves used in right ventricular outflow tract reconstruction for congenital heart disease. Circulation 2000;102:III130-5. doi: 10.1161\/01.cir.102.suppl_3.iii-130.","DOI":"10.1161\/01.CIR.102.suppl_3.III-130"},{"key":"ref-14","doi-asserted-by":"crossref","unstructured":"Batlivala SP, Emani S, Mayer JE, McElhinney DB. Pulmonary valve replacement function in adolescents: A comparison of bioprosthetic valves and homograft conduits. Ann Thorac Surg 2012;93:2007-16. doi: 10.1016\/j.athoracsur.2012.02.039.","DOI":"10.1016\/j.athoracsur.2012.02.039"},{"key":"ref-15","doi-asserted-by":"crossref","unstructured":"Caldarone CA, McCrindle BW, Van Arsdell GS, Coles JG, Webb G, Freedom RM, et al. Independent factors associated with longevity of prosthetic pulmonary valves and valved conduits. J Thorac Cardiovasc Surg 2000;120:1022-30. doi: 10.1067\/mtc.2000.110684.","DOI":"10.1067\/mtc.2000.110684"},{"key":"ref-16","doi-asserted-by":"crossref","unstructured":"Holst KA, Dearani JA, Burkhart HM, Connolly HM, Warnes CA, Li Z, et al. Risk factors and early outcomes of multiple reoperations in adults with congenital heart disease. Ann Thorac Surg 2011;92:122-8. doi: 10.1016\/j. athoracsur.2011.03.102.","DOI":"10.1016\/j.athoracsur.2011.03.102"},{"key":"ref-17","doi-asserted-by":"crossref","unstructured":"Villa-Hincapie CA, Carreno-Jaimes M, Obando-Lopez CE, Camacho-Mackenzie J, Uma\u00f1a-Mallarino JP, SandovalReyes NF. Risk factors for mortality in reoperations for pediatric and congenital heart surgery in a developing country. World J Pediatr Congenit Heart Surg 2017;8:435-9. doi: 10.1177\/2150135117704657.","DOI":"10.1177\/2150135117704657"},{"key":"ref-18","doi-asserted-by":"crossref","unstructured":"Megaly M, Han K, Sedhom R, Aboulhosn J, Moga F, Mudy K, et al. Outcomes of percutaneous and surgical pulmonary valve implantation. Cardiovasc Revasc Med 2021;32:27-32. doi: 10.1016\/j.carrev.2020.12.035.","DOI":"10.1016\/j.carrev.2020.12.035"},{"key":"ref-19","doi-asserted-by":"crossref","unstructured":"Chatterjee A, Bhatia N, Torres MG, Cribbs MG, Mauchley DC, Law MA. Comparison of transcatheter pulmonic valve implantation with surgical pulmonic valve replacement in adults (from the National Inpatient Survey Dataset). Am J Cardiol 2020;125:135-9. doi: 10.1016\/j.amjcard.2019.09.031.","DOI":"10.1016\/j.amjcard.2019.09.031"},{"key":"ref-20","doi-asserted-by":"crossref","unstructured":"\u00c7ekirdek\u00e7i EI, Bugan B, Onar L\u00c7, \u00c7ekirdek\u00e7i A. Infective endocarditis after transcatheter approach versus surgical pulmonary valve replacement: A meta-analysis. Turk Gogus Kalp Dama 2022;30:472-83. doi: 10.5606\/tgkdc. dergisi.2022.23506.","DOI":"10.5606\/tgkdc.dergisi.2022.23506"},{"key":"ref-21","doi-asserted-by":"crossref","unstructured":"McElhinney DB. Reflection and Rationalization: Making Sense of the Literature on Endocarditis After Transcatheter Pulmonary Valve Replacement. Circ Cardiovasc Interv 2017;10:e004983. doi: 10.1161\/ CIRCINTERVENTIONS.117.004983.","DOI":"10.1161\/CIRCINTERVENTIONS.117.004983"},{"key":"ref-22","doi-asserted-by":"crossref","unstructured":"Carr M, Bergersen L, Marshall AC, Keane JF, Lock JE, Emani SM, et al. Bare metal stenting for obstructed small diameter homograft conduits in the right ventricular outflow tract. Catheter Cardiovasc Interv 2013;81:E44-52. doi: 10.1002\/ccd.24369.","DOI":"10.1002\/ccd.24369"},{"key":"ref-23","doi-asserted-by":"crossref","unstructured":"Peng LF, McElhinney DB, Nugent AW, Powell AJ, Marshall AC, Bacha EA, et al. Endovascular stenting of obstructed right ventricle-to-pulmonary artery conduits: A 15-year experience. Circulation 2006;113:2598-605. doi: 10.1161\/ CIRCULATIONAHA.105.607127.","DOI":"10.1161\/CIRCULATIONAHA.105.607127"},{"key":"ref-24","doi-asserted-by":"crossref","unstructured":"Aggarwal S, Garekar S, Forbes TJ, Turner DR. Is stent placement effective for palliation of right ventricle to pulmonary artery conduit stenosis? J Am Coll Cardiol 2007;49:480-4. doi: 10.1016\/j.jacc.2006.09.037.","DOI":"10.1016\/j.jacc.2006.09.037"},{"key":"ref-25","doi-asserted-by":"crossref","unstructured":"Ran L, Wang W, Secchi F, Xiang Y, Shi W, Huang W. Percutaneous pulmonary valve implantation in patients with right ventricular outflow tract dysfunction: A systematic review and meta-analysis. Ther Adv Chronic Dis 2019;10:2040622319857635. doi: 10.1177\/2040622319857635.","DOI":"10.1177\/2040622319857635"},{"key":"ref-26","doi-asserted-by":"crossref","unstructured":"Lawley CM, Tanous D, O'Donnell C, Anderson B, Aroney N, Walters DL, et al. Ten years of percutaneous pulmonary valve implantation in Australia and New Zealand. Heart Lung Circ 2022;31:1649-57. doi: 10.1016\/j.hlc.2022.07.008.","DOI":"10.1016\/j.hlc.2022.07.008"},{"key":"ref-27","doi-asserted-by":"crossref","unstructured":"Lurz P, Coats L, Khambadkone S, Nordmeyer J, Boudjemline Y, Schievano S, et al. Percutaneous pulmonary valve implantation: Impact of evolving technology and learning curve on clinical outcome. Circulation 2008;117:1964-72. doi: 10.1161\/CIRCULATIONAHA.107.735779.","DOI":"10.1161\/CIRCULATIONAHA.107.735779"},{"key":"ref-28","doi-asserted-by":"crossref","unstructured":"Tarzia P, Conforti E, Giamberti A, Varrica A, Giugno L, Micheletti A, et al. Percutaneous management of failed bioprosthetic pulmonary valves in patients with congenital heart defects. J Cardiovasc Med (Hagerstown) 2017;18:430-5. doi: 10.2459\/JCM.0000000000000486.","DOI":"10.2459\/JCM.0000000000000486"},{"key":"ref-29","doi-asserted-by":"crossref","unstructured":"Langhammer F, Lehner A, Haas NA, Jakob A. Percutaneous pulmonary valve implantation in a dysfunctional Trifecta\u00ae bioprothesis after high-pressure balloon fracturing. Catheter Cardiovasc Interv 2020;95:1310-3. doi: 10.1002\/ccd.28781.","DOI":"10.1002\/ccd.28781"},{"key":"ref-30","doi-asserted-by":"crossref","unstructured":"Tanase D, Grohmann J, Schubert S, Uhlemann F, Eicken A, Ewert P. Cracking the ring of Edwards Perimount bioprosthesis with ultrahigh pressure balloons prior to transcatheter valve in valve implantation. Int J Cardiol 2014;176:1048-9. doi: 10.1016\/j.ijcard.2014.07.175.","DOI":"10.1016\/j.ijcard.2014.07.175"},{"key":"ref-31","doi-asserted-by":"crossref","unstructured":"Gillespie MJ, Rome JJ, Levi DS, Williams RJ, Rhodes JF, Cheatham JP, et al. Melody valve implant within failed bioprosthetic valves in the pulmonary position: A multicenter experience. Circ Cardiovasc Interv 2012;5:862-70. doi: 10.1161\/CIRCINTERVENTIONS.112.972216.","DOI":"10.1161\/CIRCINTERVENTIONS.112.972216"},{"key":"ref-32","doi-asserted-by":"crossref","unstructured":"Kwak JG, Lee C, Lee M, Lee CH, Jang SI, Lee SY, et al. Does implantation of larger bioprosthetic pulmonary valves in young patients guarantee durability in adults? Durability analysis of stented bioprosthetic valves in the pulmonary position in patients with Tetralogy of Fallot\u2020. Eur J Cardiothorac Surg 2016;49:1207-12. doi: 10.1093\/ejcts\/ezv298.","DOI":"10.1093\/ejcts\/ezv298"},{"key":"ref-33","doi-asserted-by":"crossref","unstructured":"Cabalka AK, Asnes JD, Balzer DT, Cheatham JP, Gillespie MJ, Jones TK, et al. Transcatheter pulmonary valve replacement using the melody valve for treatment of dysfunctional surgical bioprostheses: A multicenter study. J Thorac Cardiovasc Surg 2018;155:1712-24.e1. doi: 10.1016\/j.jtcvs.2017.10.143.","DOI":"10.1016\/j.jtcvs.2017.10.143"},{"key":"ref-34","doi-asserted-by":"crossref","unstructured":"Rod\u00e9s-Cabau J, Houde C, Perron J, Benson LN, Pibarot P. Delayed improvement in valve hemodynamic performance after percutaneous pulmonary valve implantation. Ann Thorac Surg 2008;85:1787-8. doi: 10.1016\/j.athoracsur.2007.11.007.","DOI":"10.1016\/j.athoracsur.2007.11.007"},{"key":"ref-35","doi-asserted-by":"crossref","unstructured":"Callahan R, Bergersen L, Baird CW, Porras D, Esch JJ, Lock JE, et al. Mechanism of valve failure and efficacy of reintervention through catheterization in patients with bioprosthetic valves in the pulmonary position. Ann Pediatr Cardiol 2017;10:11-7. doi: 10.4103\/0974-2069.197049.","DOI":"10.4103\/0974-2069.197049"},{"key":"ref-36","doi-asserted-by":"crossref","unstructured":"Le Ruz R, Plessis J, Houeijeh A, Baruteau AE, Le Gloan L, Warin Fresse K, et al. Edwards SAPIEN XT transcatheter pulmonary valve implantation: 5-Year follow-up in a French Registry. Catheter Cardiovasc Interv 2021;98:990-9. doi: 10.1002\/ccd.29862.","DOI":"10.1002\/ccd.29862"},{"key":"ref-37","doi-asserted-by":"crossref","unstructured":"McElhinney DB, Hellenbrand WE, Zahn EM, ones TK, Cheatham JP, Lock JE, et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation 2010;122:507- 16. doi: 10.1161\/CIRCULATIONAHA.109.921692.","DOI":"10.1161\/CIRCULATIONAHA.109.921692"}],"container-title":["Turkish Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/tgkdc.dergisi.org\/uploads\/pdf\/pdf_TGKDC_3847.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/tgkdc.dergisi.org\/uploads\/pdf\/pdf_TGKDC_3847.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:52:53Z","timestamp":1782222773000},"score":1,"resource":{"primary":{"URL":"https:\/\/tjtcvs.org\/articles\/doi\/tgkdc.dergisi.2025.26622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1,1]]}},"URL":"https:\/\/doi.org\/10.5606\/tgkdc.dergisi.2025.26622","relation":{},"ISSN":["1301-5680","2149-8156"],"issn-type":[{"value":"1301-5680","type":"print"},{"value":"2149-8156","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,1]]}}}